Article Versions Notes

Feemster K, Hausdorff WP, Banniettis N, Platt H, Velentgas P, Esteves-Jaramillo A, Burton RL, Nahm MH, Buchwald UK. Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development. Vaccines. 2024; 12(9):974. https://doi.org/10.3390/vaccines12090974

Feemster, Kristen, William P. Hausdorff, Natalie Banniettis, Heather Platt, Priscilla Velentgas, Alejandra Esteves-Jaramillo, Robert L. Burton, Moon H. Nahm, and Ulrike K. Buchwald. 2024. "Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development" Vaccines 12, no. 9: 974. https://doi.org/10.3390/vaccines12090974

Feemster, K., Hausdorff, W. P., Banniettis, N., Platt, H., Velentgas, P., Esteves-Jaramillo, A., Burton, R. L., Nahm, M. H., & Buchwald, U. K. (2024). Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development. Vaccines, 12(9), 974. https://doi.org/10.3390/vaccines12090974